|
1
|
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$75.4M
|
+$27.7M
|
+3,225,141
|
+44%
|
|
|
2
|
Wellington Management Group
Boston,
Massachusetts
|
$74.1M
|
+$6.33M
|
+736,709
|
+8%
|
|
|
3
|
Perceptive Advisors
New York
|
$66.7M
|
+$11.1M
|
+1,297,297
|
+16%
|
|
|
4
|
Baker Bros. Advisors
New York
|
$51.7M
|
+$7.15M
|
+832,432
|
+13%
|
|
|
5
|
|
$46.5M
|
-$29.7M
|
-3,459,460
|
-35%
|
|
|
6
|
Vestal Point Capital
New York
|
$44.6M
|
+$21.7M
|
+2,525,000
|
+67%
|
|
|
7
|
Paradigm Biocapital Advisors
New York
|
$38.5M
|
+$13M
|
+1,509,547
|
+39%
|
|
|
8
|
Suvretta Capital Management
New York
|
$36M
|
+$43.5M
|
+5,065,277
|
New
|
|
|
9
|
Braidwell
Stamford,
Connecticut
|
$24.9M
|
+$16M
|
+1,856,400
|
+113%
|
|
|
10
|
|
$22M
|
+$9.29M
|
+1,081,081
|
+54%
|
|
|
11
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$17.5M
|
-$8.88M
|
-1,032,910
|
-30%
|
|
|
12
|
|
$17.3M
|
+$19.5M
|
+2,274,475
|
+1,391%
|
|
|
13
|
|
$16.9M
|
+$19.5M
|
+2,266,141
|
+1,983%
|
|
|
14
|
Frazier Life Sciences Management
Palo Alto,
California
|
$15.3M
|
+$6.82M
|
+793,200
|
+59%
|
|
|
15
|
Woodline Partners
San Francisco,
California
|
$14.5M
|
-$4.02M
|
-467,738
|
-19%
|
|
|
16
|
RA Capital Management
Boston,
Massachusetts
|
$12.4M
|
–
|
–
|
–
|
|
|
17
|
Wasatch Advisors
Salt Lake City,
Utah
|
$6.8M
|
+$726K
|
+84,541
|
+10%
|
|
|
18
|
Sphera Funds Management
Tel Aviv,
Israel
|
$6.55M
|
+$1.72M
|
+200,000
|
+28%
|
|
|
19
|
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
$4.96M
|
–
|
–
|
–
|
|
|
20
|
|
$4.88M
|
-$150K
|
-17,474
|
-2%
|
|
|
21
|
683 Capital Management
New York
|
$4.62M
|
-$430K
|
-50,000
|
-7%
|
|
|
22
|
Artisan Partners
Milwaukee,
Wisconsin
|
$4.59M
|
-$135K
|
-15,710
|
-2%
|
|
|
23
|
Nantahala Capital Management
New Canaan,
Connecticut
|
$4.12M
|
-$402K
|
-46,803
|
-7%
|
|
|
24
|
Schroder Investment Management Group
London,
United Kingdom
|
$2.95M
|
+$1.27M
|
+147,547
|
+53%
|
|
|
25
|
|
$2.88M
|
+$1.07M
|
+125,000
|
+45%
|
|
